ArticleACS omega2025
Biopolymeric Films from the White Rind of Watermelon (
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we developed biopolymeric films derived from watermelon white rind (WF) as a platform for the localized delivery of 5-fluorouracil (5-FU). The films were obtained by solvent casting and subjected to comprehensive physicochemical characterization, confirming the successful incorporation of 5-FU and the biocompatibility of the control WF films. Biological assays were performed using murine melanoma (B16-F10) and human keratinocyte (HaCaT) cell lines. WF-5FU films significantly reduced the cell viability, clonogenic survival, and migration in both models. The cytotoxic effects were more pronounced in B16-F10 cells, confirming their higher sensitivity to the treatment. The micronucleus (MN) assay revealed a concentration-dependent increase in mutagenicity, consistent with the known genotoxic profile of 5-FU. Control films did not induce cytotoxic or genotoxic effects. Overall, WF-based biopolymeric films demonstrated favorable safety in the absence of drug loading and exhibited antitumor activity when loaded with 5-FU. These findings support their potential as a sustainable and effective topical delivery system for localized skin cancer therapy. Further in vivo and clinical investigations are needed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.